Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

References

Page 1

	Year	Citations
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. M Endoh, Toru Yanagisawa, N Taira, PubMed Cardiac MuscleIntracellular Calcium TransientsCyclic Amp LevelsCellular PhysiologyNeuromuscular Blockade	1986	173
Effects of new inotropic agents on Ca++ sensitivity of contractile proteins. Rüegg Jc PubMed Cardiac MuscleEngineeringMechanotransductionBiomedical EngineeringCellular Physiology	1986	96
Phosphodiesterase-inhibiting properties of newer inotropic agents. Hasso Scholz, Wieland Meyer PubMed Camp SystemMolecular PharmacologyCardiac MuscleHeart FailureBiochemistry	1986	90
Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties Pieter D. Verdouw, J. M. Hartog, Dirk J. Duncker, European Journal of Pharmacology MedicinePhysiologyCardiovascular PharmacologyInotropic PropertiesPharmacotherapy	1986	82
UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle P. Honerj�ger, Alexander Heiss, M. Sch�fer-Korting, Naunyn-Schmiedeberg s Archives of Pharmacology Cardiac MuscleUd-cg 115Muscle FunctionSkeletal MuscleMedicine	1984	74
Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone. Rüegg Jc, Gabriele Pfitzer, D Eubler, PubMed Cardiac MuscleMuscle PhysiologySkinned FibresEngineeringHealth Sciences	1984	57
Hemodynamic Profile of the Cardiotonic Agent Pimobendan J. C. A. van Meel, W. Diederen Journal of Cardiovascular Pharmacology HypertensionHeart FailureCardiovascular DiseasePositive Inotropic EffectsMedicine	1989	57
Evaluating the efficacy of new inotropic agents Eugene Braunwald, Wilson S. Colucci Journal of the American College of Cardiology Experimental TherapeuticPharmacotherapyInnovative TreatmentNew Inotropic AgentsMedicine	1984	45
Cardiovascular Effects and Plasma Level Profile of Pimobendan (UD-CG 115 BS) and Its Metabolite UD-CG 212 in Patients with Congestive Heart Failure After Single and Repeated Oral Dosing F Hagemeijer, Hetty J. Brand, Willy Roth Journal of Cardiovascular Pharmacology	1989	37
Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts. Christian Berger, Wieland Meyer, Hasso Scholz, PubMed Benzimidazole Derivatives PimobendanBenzimidazole X HclCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1985	36

Page 1